Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes
Clinical trial NCT06825182 · RECRUITING
Trial details
- NCT number
- NCT06825182
- Sponsor
- Nanjing First Hospital, Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-07
- Primary completion
- 2025-08-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.